Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells

References

• Zhang Y, Zhou H. LncRNA BCAR4 promotes liver cancer progression by upregulating ANAPC11 expression through sponging miR‐1261. Int J Mol Med. 2020;46(1):159–166.
   PubMed Web of Science ®Google Scholar
• Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020;1873(1):188314.
   PubMed Web of Science ®Google Scholar
• Harris PS, Hansen RM, Gray ME, et al. Hepatocellular carcinoma surveillance: an evidence-based approach. World J Gastroenterol. 2019;25(13):1550–1559.
   PubMed Web of Science ®Google Scholar
• van Tienderen TG, Koerkamp BG, IJzermans JNM, et al. Recreating tumour complexity in a dish: organoid models to study liver cancer cells and their extracellular environment. Cancers. 2019;11(11):1706.
   PubMed Web of Science ®Google Scholar
• Ndom P. Cancer prevention in Africa: liver cancer. Ecancermedicalscience. 2019;13:950.
   PubMed Web of Science ®Google Scholar
• Ranganathan S, Lopez-Terrada D, Alaggio R. Hepatoblastoma and pediatric hepatocellular carcinoma: an update. Pediatr Dev Pathol. 2020;23(2):79–95.
   PubMed Web of Science ®Google Scholar
• Aldrighetti L, Pulitanò C, Catena M, et al. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion. Ann Surg Oncol. 2009;16(5):1254–1254.
   PubMed Web of Science ®Google Scholar
• Rong B, Zhang Q, Wan J, et al. Ribosome 18S m(6)a methyltransferase METTL5 promotes translation initiation and breast cancer cell growth. Cell Rep. 2020;33(12):108544.
   PubMed Web of Science ®Google Scholar
• Liu X, Ma H, Ma L, et al. The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma. Bioengineered. 2022;13(3):5525–5536.
   PubMed Web of Science ®Google Scholar
• Yan X, Zhao X, Yan Q, et al. Analysis of the role of METTL5 as a hub gene in lung adenocarcinoma based on a weighted gene co-expression network. Math Biosci Eng. 2021;18(5):6608–6619.
   PubMedGoogle Scholar
• Huang H, Li H, Pan R, et al. Ribosome 18S m(6)a methyltransferase METTL5 promotes pancreatic cancer progression by modulating c‐Myc translation. Int J Oncol. 2022;60(1):31.
   PubMed Web of Science ®Google Scholar
• Yuan M, Guo XL, Chen JH, et al. Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway. neo. 2022;69(04):807–819.
   Google Scholar
• Francica G, Borzio M. Status of, and strategies for improving, adherence to HCC screening and surveillance. J Hepatocell Carcinoma. 2019;6:131–141.
   PubMed Web of Science ®Google Scholar
• Viveiros P, Riaz A, Lewandowski RJ, et al. Current state of liver-directed therapies and combinatory approaches with systemic therapy in hepatocellular carcinoma (HCC). Cancers. 2019;11(8):1085.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Huang MB, Gao Z, Xia M, et al. Improved aitongxiao prescription (I-ATXP) induces apoptosis, cell cycle arrest and blocks exosomes release in hepatocellular carcinoma (HCC) cells. Int J Physiol Pathophysiol Pharmacol. 2022;14(2):90–113.
   PubMedGoogle Scholar
• Zhang W, Xiao P, Tang J, et al. m6A regulator-mediated tumour infiltration and methylation modification in cervical cancer microenvironment. Front Immunol. 2022;13:888650.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wu Q, Li B, et al. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer. 2020;19(1):53.
   Web of Science ®Google Scholar
• Pan Y, Xiao K, Li Y, et al. RNA N6-methyladenosine regulator-mediated methylation modifications pattern and immune infiltration features in glioblastoma. Front Oncol. 2021;11:632934.
   PubMed Web of Science ®Google Scholar
• Wei C, Liang S, Jin L, et al. m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer. Theranostics. 2021;11(5):2201–2217.
   PubMed Web of Science ®Google Scholar
• Ohaegbulam KC, Assal A, Lazar-Molnar E, et al. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med. 2015;21(1):24–33.
   PubMed Web of Science ®Google Scholar
• Dermani FK, Samadi P, Rahmani G, et al. PD-1/PD-L1 immune checkpoint: potential target for cancer therapy. J Cell Physiol. 2019;234(2):1313–1325.
   PubMed Web of Science ®Google Scholar
• Calderaro J, Rousseau B, Amaddeo G, et al. PD-L1 expression in hepatocellular carcinoma: relationship with clinical and pathological features. Hepatology. 2016;64(6):2038–2046.
   PubMed Web of Science ®Google Scholar
• Finkelmeier F, Canli Z, Tal A, et al. High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis. Eur J Cancer. 2016;59:152–159.
   PubMed Web of Science ®Google Scholar
• Ke M-Y, Xu T, Fang Y, et al. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation. Cancer Lett. 2021;513:14–25.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou T, Cheng X, et al. microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3. Bioengineered. 2022;13(3):4730–4743.
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22–35.
   PubMed Web of Science ®Google Scholar
• Gabay M, Li Y, Felsher DW. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harbor Perspect Med. 2014;4(6):a014241.
   PubMed Web of Science ®Google Scholar
• Schaub FX, Dhankani V, Berger AC, et al. Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas. Cell Syst. 2018;6(3):282–300.e2.
   PubMed Web of Science ®Google Scholar
• Yao L, Zou X, Liu L. The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol. 2019;12(9):3329–3343.
   PubMed Web of Science ®Google Scholar
• Zhang P, Yang X, Zha Z, et al. CBX3 regulated by miR-139 promotes the development of HCC by regulating cell cycle progression. Cell Cycle. 2022;21(16):1740–1752.
   PubMed Web of Science ®Google Scholar